2-chloro-n(6)cyclopentyladenosine has been researched along with tetradecanoylphorbol acetate in 3 studies
Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (tetradecanoylphorbol acetate) | Trials (tetradecanoylphorbol acetate) | Recent Studies (post-2010) (tetradecanoylphorbol acetate) |
---|---|---|---|---|---|
252 | 0 | 43 | 31,050 | 61 | 2,217 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lasley, RD; Mentzer, RM; Noble, MA; Paulsen, KL | 1 |
Adkins, WK; Allison, RC; Barnard, JW; Moore, TM; Prasad, VR; Taylor, AE | 1 |
Backx, PH; Batthish, M; Diaz, RJ; Wilson, GJ; Zeng, HP | 1 |
3 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and tetradecanoylphorbol acetate
Article | Year |
---|---|
Adenosine attenuates phorbol ester-induced negative inotropic and vasoconstrictive effects in rat hearts.
Topics: Adenosine; Animals; Coronary Circulation; Diglycerides; Heart; In Vitro Techniques; Indoles; Male; Maleimides; Myocardial Contraction; Perfusion; Phenethylamines; Pressure; Rats; Rats, Wistar; Receptors, Purinergic P1; Tetradecanoylphorbol Acetate; Vasoconstriction | 1994 |
Adenosine prevents PMA-induced lung injury via an A2 receptor mechanism.
Topics: Adenosine; Animals; Blood Pressure; Capillary Permeability; Cyclic AMP; Dogs; Endothelium; Female; In Vitro Techniques; Isoproterenol; Lung Diseases; Male; Neutrophils; Pulmonary Circulation; Purinergic Antagonists; Receptors, Purinergic; Tetradecanoylphorbol Acetate; Vascular Resistance; Xanthines | 1993 |
Pharmacological preconditioning in rabbit myocardium is blocked by chloride channel inhibition.
Topics: Adenosine; Animals; Cells, Cultured; Chloride Channels; Dose-Response Relationship, Drug; Enzyme Activators; Glycolates; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Myocardium; Perfusion; Protein Kinase C; Rabbits; Receptors, Purinergic P1; Tetradecanoylphorbol Acetate | 2002 |